XML 162 R140.htm IDEA: XBRL DOCUMENT v3.7.0.1
ADDITIONAL INFORMATION-CONDENSED FINANCIAL STATEMENTS OF THE PARENT COMPANY (Condensed Cash Flows) (Details)
12 Months Ended
Dec. 31, 2016
CNY (¥)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
CNY (¥)
Dec. 31, 2014
CNY (¥)
Cash flows from operating activities:        
Net income ¥ 1,991,799,815 $ 286,878,844 ¥ 860,299,088 ¥ 726,196,922
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Share of income from subsidiaries (15,265,937) (2,198,752) (13,669,112) (9,549,289)
Convertible senior notes issuance cost 26,052,881
Exchange (gain)/loss (208,811,416) (30,075,101) 86,517,698 139,566,645
Changes in operating assets and liabilities:        
Decrease/(increase) in other current assets (7,621,260) (1,097,690) (52,933,157) (309,737,240)
Net cash provided/(used) by operating activities (1,802,967,740) (259,681,366) 1,339,049,528 187,067,558
Cash flows from investing activities:        
Net cash used in investing activities (6,908,979,750) (995,100,065) (3,314,637,733) (4,158,754,486)
Cash flows from financing activities:        
Proceeds from issuance of ordinary shares 770,201,158
Proceeds from exercise of share options 21,730,663 3,129,866 7,613,965 14,528,109
Proceeds from issuance of convertible senior notes 914,850,000
Repurchase of convertible senior notes (1,218,706,405) (175,530,233) (113,025,510)
Net cash provided by financing activities 7,455,061,233 1,073,752,158 3,850,632,466 5,303,692,922
Effect of foreign exchange rate changes on cash and cash equivalents 74,639,667 10,750,348 31,599,153 (11,061,518)
Net increase/(decrease) in cash and cash equivalents (1,182,246,590) (170,278,925) 1,906,643,414 1,320,944,476
Cash and cash equivalents, beginning of year 2,392,591,132 344,604,801 1,777,020,667 456,076,191
Cash and cash equivalents, end of year 2,501,417,491 360,279,057 2,392,591,132 1,777,020,667
Supplemental disclosure of non-cash investing and financing cash flow information        
Proceeds from exercise of share options received in subsequent period 6,135,783 883,737 10,210,003 226,952
Payment of issuance cost for follow-on offering in subsequent period 2,328,174
Parent Company [Member]        
Cash flows from operating activities:        
Net income 1,826,709,975 263,100,961 683,751,534 673,025,055
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Share of income from subsidiaries (1,949,659,745) (280,809,412) (692,117,271) (610,091,593)
Convertible senior notes issuance cost 26,052,881
Exchange (gain)/loss 10,073,699 1,450,914 8,235,787 (10,046,144)
Changes in operating assets and liabilities:        
(Increase)/decrease in due from subsidiaries 809,466,119 116,587,371 104,043,486 (572,172,865)
Decrease/(increase) in other current assets (4,394,605) (632,955) (1,080,514) 299,752
Increase/(Decrease) in due to a subsidiary 352,565,966 50,780,061 21,721,556 26,234,900
(Decrease)/increase in other current liabilities (10,835,057) (1,560,573) 316,410 16,276,144
Net cash provided/(used) by operating activities 1,144,168,844 164,794,588 139,442,188 (514,523,514)
Cash flows from investing activities:        
Investments in subsidiaries (5,620,197) (1,141,190,434)
Net cash used in investing activities (5,620,197) (1,141,190,434)
Cash flows from financing activities:        
Proceeds from issuance of ordinary shares 770,201,158
Proceeds from exercise of share options 21,730,663 3,129,866 7,613,965 14,528,109
Proceeds from issuance of convertible senior notes 888,797,119
Repurchase of convertible senior notes (1,218,706,405) (175,530,233) (113,025,510)
Cash paid for capped call option
Prepayment for share repurchase
Repurchase of common stock
Net cash provided by financing activities (1,196,975,742) (172,400,367) (105,411,545) 1,673,526,386
Effect of foreign exchange rate changes on cash and cash equivalents 1,937,422 279,051 2,227,375 (94,929)
Net increase/(decrease) in cash and cash equivalents (50,869,476) (7,326,728) 30,637,821 17,717,509
Cash and cash equivalents, beginning of year 55,685,082 8,020,320 25,047,261 7,329,752
Cash and cash equivalents, end of year 4,815,606 693,592 55,685,082 25,047,261
Supplemental disclosure of non-cash investing and financing cash flow information        
Proceeds from exercise of share options received in subsequent period 6,135,783 883,737 10,210,003 226,952
Payment of issuance cost for follow-on offering in subsequent period 2,328,174
Parent Company [Member] | Capped Call Options [Member]        
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Change in fair value 18,226,535 2,625,167 6,170,282 86,689,063
Parent Company [Member] | 2016 Notes [Member]        
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Change in fair value ¥ 92,015,957 $ 13,253,054 ¥ 8,400,918 ¥ (150,790,707)